3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
5
Phase 2/3
2
Phase NA
1
Phase EARLY_PHASE1
1
Phase 1/2
1
Phase 1
1
Status
Unknown
1
Terminated
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Neoplasms
3
Fatigue
2
Depression
2
Breast Neoplasms
2
Anxiety Disorders
2
Parasomnias
1
Pain
1
Interventions
Capecitabine
16
Paclitaxel
12
Docetaxel
10
Cyclophosphamide
10
Epirubicin
8
Gemcitabine
7
Letrozole
6
Doxorubicin
6
Carboplatin
6
Trastuzumab
5
Vinorelbine
4
Cisplatin
4
pertuzumab
3
exemestane
3
Neoadjuvant Therapy
3
Drug Therapy
3
Ado-Trastuzumab Emtansine
3
AC protocol
3
130-nm albumin-bound paclitaxel
3
apatinib
2
Zoledronic Acid
2
Thiotepa
2
Taxes
2
Tamoxifen
2
Standard of Care
2
Radiosurgery
2
Melatonin
2
Lapatinib
2
Injections
2
Goserelin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2/3
×
Breast Neoplasms
×
Melatonin
×
Clear all
NCT01557478
2015-01-08
MIQOL-B
Khon Kaen University
Phase 2/3
Unknown
166 enrolled
NCT01355523
2014-05-06
MELODY
Herlev Hospital
Phase 2/3
Terminated
54 enrolled
27 charts